As Palantir Technologies (PLTR) prepares to report Q4 2025 results, a wave of bullish analyst upgrades points to surging commercial demand for its AI platform, driving a debate over its valuation and long-term potential.
Oppenheimer upgrades Relay Therapeutics (RLAY) to Outperform, citing the strength of its mutant-selective inhibitor pipeline and upcoming catalysts in the breast cancer treatment arena.
Despite recent sharp declines triggered by Fed nomination news, JPMorgan analysts reaffirm a bullish $6,300 per ounce gold target for 2026, citing resilient demand from central banks and investors.
As Microsoft shares trade nearly 12% below recent highs, some analysts see a buying opportunity. We explore how selling put options could offer investors a strategic entry point while generating income.
Newly released court documents expose how former British ambassador to the U.S., Lord Peter Mandelson, shared sensitive government information with Jeffrey Epstein, including advance notice of a major Eurozone bailout. The revelations have forced his resignation from the Labour Party and intensified scrutiny of Prime Minister Keir Starmer's judgment.
The Hennepin County Medical Examiner has officially classified the January shooting death of ICU nurse Alex Pretti as a homicide, a finding that intensifies legal and public pressure on the federal agents involved amid ongoing protests and disputed official narratives.
As artificial intelligence reshapes finance, we examine whether XRP's underlying technology is built to capitalize on the trend of 'agentic AI' handling transactions, or if its potential benefits remain speculative.
Shares of PlayStudios fell sharply amid a broad gaming stock sell-off triggered by Google's unveiling of a real-time 3D world-generating AI, raising fears of industry disruption.
Shares of Werner Enterprises (WERN) surged 6% following the announcement of its acquisition of FirstFleet, a move that significantly bolsters its dedicated transportation division and market position.
In a strategic move to unify its product and technology vision, Netflix has elevated CTO Elizabeth Stone to the newly created role of Chief Product and Technology Officer. The promotion places her at the helm of the streaming giant's core product, engineering, and data divisions.
Fifth Third Bancorp has finalized its acquisition of Comerica Incorporated, a move that consolidates the Midwest banking landscape and creates the nation's ninth-largest bank with nearly $300 billion in assets.
The medical device developer Beta Bionics has received a warning letter from the U.S. Food and Drug Administration, a regulatory action stemming from a facility inspection last summer. The company maintains the letter will not disrupt its operations, manufacturing, or the planned launch of its new insulin patch pump.
In an unusual acquisition within the ETF space, the investment arm behind former President Donald Trump's social media platform is set to purchase the conservative-themed 'God Bless America' ETF, significantly expanding its asset base and adding active management to its lineup.
In a strategic reshuffle following the exit of its product chief, Netflix has merged its product and technology divisions under veteran executive Elizabeth Stone, signaling a tighter integration of engineering and user experience.
Craig-Hallum and Northland Securities have both lowered price targets for MiMedx Group (MDXG), citing near-term uncertainty following new CMS billing guidance for skin substitute products, though both firms maintain positive long-term ratings.
UPS's ambitious free cash flow target for 2026 appears to secure its hefty dividend, but a closer look reveals reliance on asset sales, deep cost cuts, and reduced capital investment—a strategy that may be mortgaging its long-term expansion.
The narrative around Chinese electric vehicles is undergoing a fundamental shift. Once known primarily for affordability, leading Chinese automakers are now challenging incumbents with rapidly improving quality, technology, and reliability, forcing a global industry recalibration.
Abbott Laboratories moves to acquire cancer-testing leader Exact Sciences in a landmark deal, signaling a strategic shift toward high-growth diagnostics while simultaneously restructuring its challenged Nutrition business.
Bank of America's stock has retreated roughly 5% over the past month, trading below key fair value estimates. Analysts are divided on whether this presents a value entry point or reflects growing market apprehension about interest margins and credit quality.
Fifth Third Bancorp has finalized its $12.3 billion acquisition of Comerica Bank, with customer system conversions and branch rebranding scheduled to begin after Labor Day. The deal reshapes Michigan's banking landscape and creates the nation's ninth-largest bank.
